BMC Medical Genomics (Aug 2025)
CUX1 variant and 9p deletion: expanding the spectrum and resolving variable GDD/ID in a family
Abstract
Abstract Background Intellectual disability (ID) significantly impacts individual development and imposes a societal burden. Although mild ID accounts for approximately 85% of total cases, research into its genetic etiology remains relatively limited. We investigated a two-generation pedigree exhibiting varying degrees of global developmental delay (GDD) and ID. We collected clinical data from the proband and her parents, identified the genetic etiology through testing, investigated pathogenic mechanisms, and provided family genetic counseling. Methods Peripheral blood samples were collected from pedigree members for chromosomal karyotyping and genomic DNA extraction. Trio exome sequencing (Trio-ES) was performed on the DNA samples. Candidate variants identified were validated using Sanger sequencing, and their pathogenicity was assessed in accordance with the standards and guidelines of the American College of Medical Genetics and Genomics (ACMG). Results The proband, a 2-year-old female, presented with GDD. Her father exhibited borderline intellectual disability, while her mother had mild intellectual disability. ES analysis revealed: Exome sequencing identified a unknown inheritance heterozygous variant (NM_001202543.2[CUX1]: c.2637G > A [p.Trp879*]) in both the proband and her father, classified as likely pathogenic. The mother carried an 8.60 Mb deletion (seq[hg19]del(9)(p24.3p24.1), which was classified as a pathogenic copy number variant (CNV). Conclusion Our findings expand the spectrum of genetic variations associated with CUX1-related disorders. The conclusive molecular diagnosis established through genetic testing not only facilitated accurate genetic counseling but also reduced the time and economic burdens associated with the diagnostic odyssey.
Keywords